2015-2016 Influenza Activity and Clinical Recommendations

Date:Tuesday, February 16, 2016

Presenter(s)

Overview

Influenza activity is increasing across the United States and CDC has received several reports of severe influenza illness. Since October 2015, CDC has detected co-circulation of multiple seasonal influenza virus types and sub-types, with recent reports of severe respiratory illness among young- to middle-aged adults with H1N1pdm09 virus infection. During this COCA Webinar, clinicians will learn about 2015-2016 influenza activity, hear an overview of CDC’s current recommendations for vaccination and antiviral medications, and gain insight into data supporting the recommendations.

Objectives

• Describe the current status of influenza activity in the United States
• Discuss the circulating influenza strains seen this season and the implications for clinicians
• Discuss the use of influenza diagnostic tests and their role in clinical care
• Discuss antiviral treatment and implications for patient evaluation, treatment and testing

Call Materials

• Slides:View Now
• Transcript: Read Now
• Audio:Listen Now
• Webcast:Watch Now

Additional Resources

• CDC Influenza Information for Health Professionals
• CDC Influenza Activity and Surveillance
• CDC Influenza Antiviral Medications: Summary for Clinicians
• CDC Influenza Prevention and Control of Seasonal Influenza with Vaccines
• Health Alert Network (HAN) – CDC Health Advisory: Flu Season Begins: Severe Influenza Illness Reported.
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2015–16 Influenza Season. 
• Prevention Strategies for Seasonal Influenza in Healthcare Settings

Call Format

• Audio conference call on 2/16/16: 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 2/16/16
• Materials: PowerPoint slide set

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-083-L04-P and enduring 0387-0000-16-083-H04-P course category.

Course Category: This activity has been designated as knowledge-based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.

There is no cost for this program.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC does not accept commercial support.